News 23 | 12 | 22 Protinhi Therapeutics semi-finalist iin ZELSIF Protinhi Therapeutics, a company located at Noviotech Campus Nijmegen, is nominated as a semi-finalist in ZELSIF this year, and will be presenting their journey to European and Chinese medical experts and investors during the event on the 16th of December. The ZELSIF 2022 International Top 15 winners will receive the “ZELSIF 2022” award, which goes along with the privileged opportunity to introduce their solutions to Chinese healthcare experts, investors, and industrials through an online pitch presentation. In the next two weeks, the semi-finalist companies will compete for the top 7 final winners who will receive further awards in cash. Protinhi Therapeutics is an early-stage biotech company aiming to combat (emerging) viral infectious diseases with a high unmet medical need via protease inhibition. With their proprietary technology platform, they are actively developing novel antiviral drugs that inhibit proteases and block viral replication. The aim for easy-to-administer drugs able to treat in epidemic and pandemic situations. https://set.kuleuven.be/lhtc/News Posted by Karina Garcia, Kadans Science Partner. Briskr News 06 | 02 | 26 HERACLES – Removing barriers to data reuse in the Netherlands Like the legendary Heracles, who overcame seemingly impossible challenges, Johnson & Johnson joined forces with twelve stakeholders in the Netherlands to unlock the value of... 05 | 02 | 26 A heartfelt thank you to Bas Doets After more than 3,5 years of dedication, strategic insight and unwavering commitment to the growth of the Lifeport health & hightech ecosystem, Bas Doets has... 04 | 02 | 26 Digital Health Challenge Lab: van uitdaging naar impact De eerste concrete resultaten van het Digital Health Challenge Lab (DHCL) zijn binnen! DHCL is een vooruitstrevend open innovatieprogramma waarin partners uit wonen, zorg en... All news
06 | 02 | 26 HERACLES – Removing barriers to data reuse in the Netherlands Like the legendary Heracles, who overcame seemingly impossible challenges, Johnson & Johnson joined forces with twelve stakeholders in the Netherlands to unlock the value of...
05 | 02 | 26 A heartfelt thank you to Bas Doets After more than 3,5 years of dedication, strategic insight and unwavering commitment to the growth of the Lifeport health & hightech ecosystem, Bas Doets has...
04 | 02 | 26 Digital Health Challenge Lab: van uitdaging naar impact De eerste concrete resultaten van het Digital Health Challenge Lab (DHCL) zijn binnen! DHCL is een vooruitstrevend open innovatieprogramma waarin partners uit wonen, zorg en...
